Hinal Lukha

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.

C. Brander, V. Miller, T. Peto, 2021, Cell reports.

Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV

Hongbo Deng, A. Winston, C. Sabin, 2022, Kidney international reports.

Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV

Hongbo Deng, A. Winston, C. Sabin, 2021, Kidney international reports.

No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV.

A. Milinkovic, L. Waters, O. Stirrup, 2020, AIDS.

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections

Robert L. Goldstone, Naomi R. Waterlow, Quentin J. Leclerc, 2020, BMC Medicine.

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Robert L. Goldstone, James M. A. Turner, J. Ule, 2020, The Lancet.

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

M. Johnson, V. Miller, T. Peto, 2020, The Lancet.

Incoming HIV Virion-Derived Gag Spacer Peptide 2 (p1) is a Target of Effective CD8+ T Cell Antiviral Responses

C. Brander, V. Miller, T. Peto, 2020, SSRN Electronic Journal.